The emergence of Trichophyton indotineae : Implications for clinical practice
International Journal of Dermatology · 2023-07 · 62 (7) · 857-861
DOI: 10.1111/ijd.16362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, online erschienen am 22.07.2022. Verfasst von Aditya K Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mediprobe Research Inc., London, Ontario, Canada. Hauptthemen laut MEDLINE: Trichophyton, Antifungal Agents. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Emergence and increase of terbinafine‐resistant dermatophytosis led to the identification of Trichophyton mentagrophytes internal transcriber space (ITS) genotype VIII in 2017, later renamed as Trichophyton indotineae and classified as a separate species in 2020. With its suspected origin in South Asia, this novel strain has emerged in Bahrain, Canada, Denmark, Finland, France, Germany, India, Iran, Japan, Russia, and Switzerland, with its spread attributed primarily to travel and migration. Diagnosis using routine mycology laboratory techniques is unable to distinguish T. indotineae from T. mentagrophytes and T. interdigitale ; specific identification requires genomic sequencing to identify unique, specific markers. One speculated reason for this recent outbreak is the unrestricted use of topical steroid creams and antifungal agents. Patients with extensive tinea corporis and cruris due to T. indotineae present with inflammatory red plaques in multiple body sites. The majority of these infections prove to be resistant to conventional antifungals, including allylamines and azoles (itraconazole and fluconazole), thus emphasizing the need for antifungal susceptibility testing before treatment initiation and for reassessing in nonresponsive patients. Molecular studies have identified several point mutations in the ERG1 (terbinafine resistance) and ERG11 (azole resistance) genes, which need to be analyzed further. Use of relatively new agents, such as voriconazole and luliconazole, as well as device modalities and combination therapy, could be investigated for recalcitrant T. indotineae infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mediprobe Research Inc., London, Ontario, Canada.
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Sporometrics, Toronto, Ontario, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Aditya K Gupta, Maanasa Venkataraman, Deanna C Hall, Elizabeth A Cooper, Richard C Summerbell
Zitieren
APA
Gupta, A. K., Venkataraman, M., Hall, D. C., Cooper, E. A., & Summerbell, R. C. (2023). The emergence of Trichophyton indotineae : Implications for clinical practice. International Journal of Dermatology, 62(7), 857-861. https://doi.org/10.1111/ijd.16362
Vancouver
Gupta AK, Venkataraman M, Hall DC, Cooper EA, Summerbell RC. The emergence of Trichophyton indotineae : Implications for clinical practice. International Journal of Dermatology. 2023;62(7):857-861. doi:10.1111/ijd.16362
BibTeX
@article{Gupta2023,
author = {Gupta, Aditya K and Venkataraman, Maanasa and Hall, Deanna C and Cooper, Elizabeth A and Summerbell, Richard C},
title = {The emergence of Trichophyton indotineae : Implications for clinical practice},
journal = {International Journal of Dermatology},
year = {2023},
volume = {62},
number = {7},
pages = {857--861},
doi = {10.1111/ijd.16362}
}
EUVIMED